Brendan Fee
Morgan, Lewis & Bockius LLPMorgan, Lewis & Bockius LLP‘s attorneys boast a ’breadth and depth of knowledge’ across a range of sectors, with particular strength in assisting healthcare, tech, and financial services clients facing FTC challenges to mergers, MDL proceedings and antitrust suits tied to drug pricing, algorithmic pricing, no poach and wage fixing allegations. Philadelphia-based Steven Reed spearheads the firm’s global antitrust group, representing clients in antitrust and merger suits, with a wealth of experience in the pharmaceutical industry. He is ably supported by deputy practice heads Ryan Kantor, operating out of Washington DC and appearing for clients before the FTC and DOJ, and Brendan Fee, also based in Philadelphia and noted for his advice on matters such as price-fixing and vertical restraints. In Chicago, Kenneth Kliebard defends financial services companies facing antitrust and consumer protection class actions, with Philadelphia’s Zachary Johns representing clients in civil and criminal antitrust matters, including issues of exclusive dealing, tying, and monopolization, among others.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The breadth and depth of knowledge in a variety of subject areas is off the charts! There's no issue they haven't seen before.’
Key clients
- Blue Cross Blue Shield of Louisiana
- Breckenridge Pharmaceutical, Inc.
- Aspirus
- Fanatics
- Google LLC
- Intercontinental Exchange, Inc.
- Merck & Co. Inc.
- Morgan Stanley
- Perrigo Company Plc
- Qualcomm Incorporated
- Anywhere Real Estate
- Securus Technologies Inc.
- National Auto Auction
- Sumitomo Mitsui Banking Corporation
- Takeda Pharmaceuticals
- TDK USA Corp.
- Teva Pharmaceuticals
- Uber Technologies, Inc.
- Philadelphia Orchestra Kimmel Center
Work highlights
- Represented Google in all facets of Google Play Store Antitrust Litigation, an MDL pending in the Northern District of California related to the distribution of apps by developers to end users.
- Secured a settlement with the FTC, enabling ICE to close its $11.9bn acquisition of Black Knight, Inc.
- Secured a settlement at trial for Takeda Pharmaceuticals in a lawsuit brought by drug wholesalers alleging a conspiracy among defendants to restrain trade and monopolize an alleged market for gout drug Colcrys and its AB-rated generics.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Steven Reed, Ryan Kantor, Brendan Fee